V
VAXA
Developing sustainable algae-based feed and food ingredients. The company's production facility is located in Iceland, integrated with one of the world's largest geothermal power production facility
About VAXA
VAXA Technologies is revolutionizing the production of sustainable food and nutrition through its innovative indoor vertical farming process. The company operates in the aquaculture and human nutrition markets, providing a year-round supply of fresh, live microalgae rich in Omega 3. VAXA's unique patented process converts clean energy into high-quality, carbon-neutral microalgae, which is used to improve fish yields, boost juvenile immune systems, and enhance human nutrition with protein-rich supplements and natural colorants. The company's business model focuses on selling these sustainable products to hatcheries, fisheries, and health-conscious consumers. Revenue is generated through the sale of microalgae-based products, which offer superior nutritional benefits and environmental sustainability. VAXA's multidisciplinary team of technology and biology experts, along with its advisory board of leaders in aquaculture and sustainability, ensures the highest standards in product quality and innovation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Reykjavík, Iceland
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 69.1/100
- Sub-industry
- AgriTech, Innovative Food
- Sector
- Energy, Aquaculture, Algae, Geothermal Energy, Novel Farming, Alternative Protein, Sustainable Development Goals, Enabler of Alternative Proteins
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| OtherOther financing | Apr 2021 | $0 | — | Undisclosed | — |
| SEED✓Equity / VC | Oct 2017 | $3.3M | $13M | Undisclosed | — |
Growth signals
Latest recorded traffic for VAXA is 1.6K monthly website visits, up 1233.3% over the last three months. VAXA's team declined 13% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
EIT Food
Jakore
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about VAXA on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See VAXA’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.